We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-8.74%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.03B
AUM Growth
-$97.2M
Cap. Flow
+$5.15M
Cap. Flow %
0.5%
Top 10 Hldgs %
54.98%
Holding
5,775
New
1,132
Increased
1,485
Reduced
1,487
Closed
1,545

Sector Composition

Rank Sector Weight
1 Financials 2.17%
2 Healthcare 1.69%
3 Industrials 1.67%
4 Technology 1.59%
5 Consumer Discretionary 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASTE icon
476
Astec Industries
ASTE
$1.02B
$118K 0.01%
3,516
+2,102
+149% +$79.8K
FCNCA icon
477
First Citizens BancShares
FCNCA
$25.3B
$118K 0.01%
520
-25
-5% -$6.13K
GPK icon
478
Graphic Packaging
GPK
$3.58B
$118K 0.01%
9,202
-24,037
-72% -$343K
EPD icon
479
Enterprise Products Partners
EPD
$81.7B
$117K 0.01%
4,686
+15
+0.3% +$416
HIW icon
480
Highwoods Properties
HIW
$3.47B
$117K 0.01%
+3,012
New +$121K
SRCE icon
481
1st Source
SRCE
$2.12B
$117K 0.01%
+3,798
New +$116K
TECD
482
DELISTED
Tech Data Corp
TECD
$117K 0.01%
1,702
-668
-28% -$40.9K
PRFZ icon
483
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.89B
$116K 0.01%
6,320
+4,720
+295% +$92.7K
DNB
484
DELISTED
Dun & Bradstreet
DNB
$116K 0.01%
1,100
+1,009
+1,109% +$115K
LFCR icon
485
Lifecore Biomedical
LFCR
$190M
$115K 0.01%
9,867
+9,167
+1,310% +$121K
REGN icon
486
Regeneron Pharmaceuticals
REGN
$80.8B
$115K 0.01%
248
-462
-65% -$248K
SLGN icon
487
Silgan Holdings
SLGN
$4.41B
$115K 0.01%
4,412
+3,932
+819% +$104K
CSTE icon
488
Caesarstone
CSTE
$79.5M
$114K 0.01%
+3,763
New +$196K
FRME icon
489
First Merchants
FRME
$2.67B
$114K 0.01%
+4,355
New +$113K
LYTS icon
490
LSI Industries
LYTS
$924M
$114K 0.01%
13,453
+10,488
+354% +$98.4K
SONC
491
DELISTED
Sonic Corp
SONC
$114K 0.01%
4,939
+2,842
+136% +$78.6K
TEP
492
DELISTED
Tallgrass Energy Partners, LP
TEP
$114K 0.01%
2,898
+2,797
+2,769% +$126K
SNDK
493
DELISTED
SANDISK CORP
SNDK
$114K 0.01%
2,101
+1,401
+200% +$77.4K
ICFI icon
494
ICF International
ICFI
$1.72B
$113K 0.01%
3,714
+3,197
+618% +$110K
LABD icon
495
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$57.2M
$113K 0.01%
+1
New +$70.8K
WOR icon
496
Worthington Enterprises
WOR
$2.86B
$113K 0.01%
6,949
-4,389
-39% -$71.6K
MKTO
497
DELISTED
MARKETO INC COM STK (DE)
MKTO
$113K 0.01%
+3,970
New +$112K
BMRC icon
498
Bank of Marin Bancorp
BMRC
$459M
$112K 0.01%
4,642
+4,268
+1,141% +$103K
GNW icon
499
Genworth Financial
GNW
$3.71B
$112K 0.01%
24,172
+13,302
+122% +$78.3K
NI icon
500
NiSource
NI
$20.4B
$112K 0.01%
+6,032
New +$103K

Similar funds

Tower Research Capital (TRC)'s Q3 2015 Portfolio in Review

As of Q3 2015, Tower Research Capital (TRC) held 5,775 positions worth $1.03B, down 8.6% from $1.13B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC)'s Q3 2015 filing shows 1,132 new, 1,485 increased, 1,487 reduced and 1,545 closed positions. Its largest new stake was iShares Russell 2000 ETF: 144,546 shares worth $15.8M. The largest sale was VanEck Semiconductor ETF, an estimated $34M.

By sector, the portfolio is most concentrated in Financials at 2.2% of assets, down from 2.5% a quarter earlier, followed by Healthcare and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2015 buy was iShares Russell 2000 ETF: 144,546 shares worth $15.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q3 2015, an estimated $37.1M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2015 reduction was VanEck Semiconductor ETF, cutting an estimated $34M.
  • Tower Research Capital (TRC) fully exited Vanguard Extended Market ETF in Q3 2015, selling an estimated $10M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.03B portfolio in Q3 2015.
  • Tower Research Capital (TRC) opened 1,132 new positions and closed 1,545 in Q3 2015.
  • Tower Research Capital (TRC)'s portfolio value fell 8.6% quarter-over-quarter to $1.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2015, filed 13 Nov 2015.